• 1. A novel approach to enantiopure cyclopropane compounds from biotransformation of nitriles
  Mei-Xiang Wang,Guo-Qiang Feng New J. Chem. 2002 26 1575
• 2. Modified McFadyen–Stevens reaction for a versatile synthesis of aliphatic/aromatic aldehydes: design, optimization, and mechanistic investigations
  Yuri Iwai,Takashi Ozaki,Ryo Takita,Masanobu Uchiyama,Jun Shimokawa,Tohru Fukuyama Chem. Sci. 2013 4 1111
• 3. Radiolabelling of 1,4-disubstituted 3-[18F]fluoropiperidines and its application to new radiotracers for NR2B NMDA receptor visualization
  Radouane Koudih,Gwéna?lle Gilbert,Martine Dhilly,Ahmed Abbas,Louisa Barré,Danièle Debruyne,Franck Sobrio Org. Biomol. Chem. 2012 10 8493
• 4. Efficient syntheses of four stable-isotope labeled (1R)-menthyl (1S,2S)-(+)-2-phenylcyclopropanecarboxylates
  Edmund J. Keliher,Richard C. Burrell,Harry R. Chobanian,Karina L. Conkrite,Rajesh Shukla,John E. Baldwin Org. Biomol. Chem. 2006 4 2777
• 5. Asymmetric transformations from sulfoxonium ylides
  Clarice A. D. Caiuby,Lucas G. Furniel,Antonio C. B. Burtoloso Chem. Sci. 2022 13 1192

Introduction to (1R,2R)-2-phenylcyclopropane-1-carboxylic Acid (CAS No. 3471-10-1)

Compound (1R,2R)-2-phenylcyclopropane-1-carboxylic acid, identified by the CAS number 3471-10-1, is a significant molecule in the field of organic chemistry and pharmaceutical research. This compound belongs to the class of cyclopropanecarboxylic acids, which are known for their unique structural properties and potential biological activities. The specific stereochemistry of this compound, denoted by the configuration (1R,2R), makes it a subject of considerable interest in synthetic chemistry and drug discovery.

The cyclopropane ring in (1R,2R)-2-phenylcyclopropane-1-carboxylic acid introduces a high degree of strain, which can be exploited to influence the reactivity and biological interactions of the molecule. This strain can lead to enhanced binding affinities with biological targets, making such compounds valuable scaffolds for drug development. The phenyl group attached to the cyclopropane ring further modulates the electronic and steric properties of the molecule, contributing to its diverse potential applications.

In recent years, there has been growing interest in cyclopropanecarboxylic acids due to their role as intermediates in the synthesis of various pharmacologically active compounds. For instance, studies have shown that derivatives of this class can exhibit properties such as anti-inflammatory, analgesic, and even anticancer effects. The unique structural features of (1R,2R)-2-phenylcyclopropane-1-carboxylic acid make it a promising candidate for further exploration in these areas.

One of the most compelling aspects of this compound is its synthetic versatility. The cyclopropane ring can be introduced into a wide range of molecular frameworks through various synthetic strategies, including ring-closing metathesis and cycloaddition reactions. These methods allow chemists to tailor the structure of the molecule precisely, enabling the creation of libraries of derivatives with tailored biological activities. This flexibility has made (1R,2R)-2-phenylcyclopropane-1-carboxylic acid a valuable building block in medicinal chemistry.

Recent research has also highlighted the importance of stereochemistry in determining the biological activity of cyclopropanecarboxylic acids. The (1R,2R) configuration of this compound appears to confer specific interactions with biological targets, which can be harnessed to develop novel therapeutic agents. For example, studies have demonstrated that enantiomerically pure forms of this compound can exhibit enhanced selectivity and potency compared to racemic mixtures. This underscores the importance of understanding and controlling stereochemistry in drug design.

The pharmacological potential of (1R,2R)-2-phenylcyclopropane-1-carboxylic acid has been further explored in several preclinical studies. These investigations have revealed that derivatives of this compound can modulate various signaling pathways involved in inflammation and pain perception. For instance, some studies suggest that certain analogs may inhibit the activity of cyclooxygenase enzymes (COX), which are key targets for nonsteroidal anti-inflammatory drugs (NSAIDs). This finding opens up new avenues for developing more effective and safer anti-inflammatory agents.

In addition to its anti-inflammatory properties, there is evidence suggesting that (1R,2R)-2-phenylcyclopropane-1-carboxylic acid and its derivatives may have applications in cancer therapy. Research has shown that some cyclopropanecarboxylic acid derivatives can induce apoptosis in cancer cells by disrupting mitochondrial function. This mechanism is distinct from traditional chemotherapeutic agents and may offer a complementary approach to cancer treatment. Further investigation into the anticancer potential of this compound is warranted.

The synthesis of complex molecules like (1R,2R)-2-phenylcyclopropane-1-carboxylic acid often requires sophisticated synthetic techniques and careful optimization. Advances in catalytic methods have made it possible to construct complex cyclic structures with high efficiency and selectivity. For example, transition metal-catalyzed reactions have enabled the introduction of functional groups at specific positions within the cyclopropane ring, allowing for precise control over molecular architecture.

The development of new synthetic methodologies has also contributed to the growing interest in cyclopropanecarboxylic acids as pharmacological tools. Techniques such as asymmetric synthesis have allowed chemists to produce enantiomerically pure forms of these compounds without resorting to chiral auxiliaries or catalysts. This advancement has not only simplified synthetic routes but also reduced costs associated with producing these valuable molecules.

In conclusion, compound (1R,2R)-2-phenylcyclopropane-1-carboxylic acid (CAS No. 3471-10-1) represents a fascinating area of research with significant potential in pharmaceutical development. Its unique structural features and stereochemistry make it a versatile scaffold for designing novel therapeutic agents with diverse biological activities. As synthetic chemistry continues to evolve, it is likely that more applications for this compound will be discovered, further solidifying its importance in medicinal chemistry.

• 5685-38-1(2-phenylcyclopropane-1-carboxylic acid)
• 23020-15-7((1S,2S)-2-phenylcyclopropane-1-carboxylic acid)
• 939-89-9(cis-2-phenylcyclopropane-1-carboxylic acid)
• 787620-71-7(Cyclopropanecarboxylic acid, 2,3-diphenyl-, (2R,3R)-)
• 389625-82-5(Cyclopropaneacetic acid, 2-carboxy-3-phenyl-, (1R,2R,3R)-rel-)
• 869941-94-6(2-(4-methylphenyl)cyclopropanecarboxylic Acid)
• 939-90-2(trans-2-phenylcyclopropane-1-carboxylic acid)
• 107077-95-2(rac trans-2-Phenylcyclopropanecarboxylic-d5 Acid)
• 389625-80-3(Cyclopropanecarboxylic acid, 2-(hydroxymethyl)-3-phenyl-,(1R,2S,3S)-rel-)
• 48126-51-8((1R,2S)-2-phenylcyclopropane-1-carboxylic acid)